Estrogen receptor alpha promotes lupus in (NZB × NZW)F1 mice in a B cell intrinsic manner

Clinical Immunology

Volumn 174, Issue , 2017, Pages 41-52

  Tabor, Dana E ^a   Gould, Karen A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

B cell; Estrogen receptor alpha; Immune cell activation; Immunologic tolerance; Lupus

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; ESTROGEN RECEPTOR ALPHA; ANTINUCLEAR ANTIBODY; CD19 ANTIGEN, MOUSE; CRE RECOMBINASE; IMMUNOGLOBULIN G; INTEGRASE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; FEMALE; GENE DELETION; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS VULGARIS; MALE; MORTALITY; MOUSE; NONHUMAN; NZBXNZW F1 MOUSE; PRIORITY JOURNAL; ANIMAL; BLOOD; GENETICS; IMMUNOLOGY; NEW ZEALAND BLACK MOUSE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD19; B-LYMPHOCYTES; ESTROGEN RECEPTOR ALPHA; FEMALE; IMMUNOGLOBULIN G; INTEGRASES; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED NZB;

EID: 84997769344     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2016.10.011     Document Type: Article

References (51)

1. [1] Azeredo da Silveira, S., Kikuchi, S., Fossati-Jimack, L., Moll, T., Saito, T., Verbeek, J.S., Botto, M., Walport, M.J., Carroll, M., Izui, S., Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J. Exp. Med. 195 (2002), 665–672.
2. [2] Korganow, A.S., Knapp, A.M., Nehme-Schuster, H., Soulas-Sprauel, P., Poindron, V., Pasquali, J.L., Martin, T., Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression. J. Autoimmun. 34 (2010), 426–434.
3. [3] Gao, N., Dresel, J., Eckstein, V., Gellert, R., Storch, H., Venigalla, R.K., Schwenger, V., Max, R., Blank, N., Lorenz, H.M., Tretter, T., Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Arthritis Rheumatol. 66 (2014), 2849–2861.
4. [4] Koide, J., Takano, M., Takeuchi, T., Hosono, O., Amano, K., Homma, M., Abe, T., Direct demonstration of immunoregulatory T-cell defects in patients with systemic lupus erythematosus. Scand. J. Immunol. 23 (1986), 449–459.
5. [5] Liossis, S.N., Ding, X.Z., Dennis, G.J., Tsokos, G.C., Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest. 101 (1998), 1448–1457.
6. [6] Kim, W.U., Min, S.Y., Hwang, S.H., Yoo, S.A., Kim, K.J., Cho, C.S., Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 161 (2010), 453–458.
7. [7] Ding, D., Mehta, H., McCune, W.J., Kaplan, M.J., Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 177 (2006), 5878–5889.
8. [8] Abe, T., Hara, M., Yamasaki, K., Homma, M., Cell-mediated immune response in systemic lupus erythematosus. In vitro cellular response to native DNA by macrophage inhibitory test. Arthritis Rheum. 16 (1973), 688–694.
9. [9] Bannister, K.M., Hay, J., Clarkson, A.R., Woodroffe, A.J., Fc-specific reticulo-endothelial clearance in systemic lupus erythematosus and glomerulonephritis. Am. J. Kidney Dis. 3 (1984), 287–292.
10. [10] Shlomchik, M.J., Madaio, M.P., Ni, D., Trounstein, M., Huszar, D., The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180 (1994), 1295–1306.
11. [11] Chan, O.T., Hannum, L.G., Haberman, A.M., Madaio, M.P., Shlomchik, M.J., A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189 (1999), 1639–1648.
12. [12] Meier, C.R., Sturkenboom, M.C., Cohen, A.S., Jick, H., Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J. Rheumatol. 25 (1998), 1515–1519.
13. [13] Costenbader, K.H., Feskanich, D., Stampfer, M.J., Karlson, E.W., Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 56 (2007), 1251–1262.
14. [14] Smithson, G., Medina, K., Ponting, I., Kincade, P.W., Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J. Immunol. 155 (1995), 3409–3417.
15. [15] Pierdominici, M., Maselli, A., Colasanti, T., Giammarioli, A.M., Delunardo, F., Vacirca, D., Sanchez, M., Giovannetti, A., Malorni, W., Ortona, E., Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol. Lett. 132 (2010), 79–85.
16. [16] Bynote, K.K., Hackenberg, J.M., Korach, K.S., Lubahn, D.B., Lane, P.H., Gould, K.A., Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB × NZW)F1 mice. Genes Immun. 9 (2008), 137–152.
17. [17] Yoachim, S.D., Nuxoll, J.S., Bynote, K.K., Gould, K.A., Estrogen receptor alpha signaling promotes Sle1-induced loss of tolerance and immune cell activation and is responsible for sex bias in B6.Sle1 congenic mice. Clin. Immunol. 158 (2015), 153–166.
18. [18] Grimaldi, C.M., Jeganathan, V., Diamond, B., Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J. Immunol. 176 (2006), 2703–2710.
19. [19] Grimaldi, C.M., Cleary, J., Dagtas, A.S., Moussai, D., Diamond, B., Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 109 (2002), 1625–1633.
20. [20] Hill, L., Jeganathan, V., Chinnasamy, P., Grimaldi, C., Diamond, B., Differential roles of estrogen receptors alpha and beta in control of B-cell maturation and selection. Mol. Med. 17 (2011), 211–220.
21. [21] Mai, T., Zan, H., Zhang, J., Hawkins, J.S., Xu, Z., Casali, P., Estrogen receptors bind to and activate the HOXC4/HoxC4 promoter to potentiate HoxC4-mediated activation-induced cytosine deaminase induction, immunoglobulin class switch DNA recombination, and somatic hypermutation. J. Biol. Chem. 285 (2010), 37797–37810.
22. [22] Pauklin, S., Sernandez, I.V., Bachmann, G., Ramiro, A.R., Petersen-Mahrt, S.K., Estrogen directly activates AID transcription and function. J. Exp. Med. 206 (2009), 99–111.
23. [23] Gould, K.A., Dietrich, W.F., Borenstein, N., Lander, E.S., Dove, W.F., Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics 144 (1996), 1769–1776.
24. [24] Lubahn, D.B., Moyer, J.S., Golding, T.S., Couse, J.F., Korach, K.S., Smithies, O., Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 11162–11166.
25. [25] Hewitt, S.C., Kissling, G.E., Fieselman, K.E., Jayes, F.L., Gerrish, K.E., Korach, K.S., Biological and biochemical consequences of global deletion of exon 3 from the ER alpha gene. FASEB J. 24 (2010), 4660–4667.
26. [26] Nelson, R.K., Gould, K.A., An Lck-cre transgene accelerates autoantibody production and lupus development in (NZB × NZW)F1 mice. Lupus 25 (2016), 137–154.
27. [27] Winuthayanon, W., Hewitt, S.C., Orvis, G.D., Behringer, R.R., Korach, K.S., Uterine epithelial estrogen receptor alpha is dispensable for proliferation but essential for complete biological and biochemical responses. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 19272–19277.
28. [28] Rickert, R.C., Roes, J., Rajewsky, K., B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25 (1997), 1317–1318.
29. [29] Loonstra, A., Vooijs, M., Beverloo, H.B., Allak, B.A., van Drunen, E., Kanaar, R., Berns, A., Jonkers, J., Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 9209–9214.
30. [30] Bassi, C., Xavier, D., Palomino, G., Nicolucci, P., Soares, C., Sakamoto-Hojo, E., Donadi, E., Efficiency of the DNA repair and polymorphisms of the XRCC1, XRCC3 and XRCC4 DNA repair genes in systemic lupus erythematosus. Lupus 17 (2008), 988–995.
31. [31] Davies, R.C., Pettijohn, K., Fike, F., Wang, J., Nahas, S.A., Tunuguntla, R., Hu, H., Gatti, R.A., McCurdy, D., Defective DNA double-strand break repair in pediatric systemic lupus erythematosus. Arthritis Rheum. 64 (2012), 568–578.
32. [32] Trebeden-Negre, H., Weill, B., Fournier, C., Batteux, F., B cell apoptosis accelerates the onset of murine lupus. Eur. J. Immunol. 33 (2003), 1603–1612.
33. [33] Denny, M.F., Chandaroy, P., Killen, P.D., Caricchio, R., Lewis, E.E., Richardson, B.C., Lee, K.D., Gavalchin, J., Kaplan, M.J., Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J. Immunol. 176 (2006), 2095–2104.
34. [34] Sharp, G.C., Irvin, W.S., LaRoque, R.L., Velez, C., Daly, V., Kaiser, A.D., Holman, H.R., Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J. Clin. Invest. 50 (1971), 350–359.
35. [35] Weitzman, R.J., Walker, S.E., Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus. Ann. Rheum. Dis. 36 (1977), 44–49.
36. [36] Mirzayan, M.J., Schmidt, R.E., Witte, T., Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford) 39 (2000), 1316–1319.
37. [37] Steward, M.W., Hay, F.C., Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin. Exp. Immunol. 26 (1976), 363–370.
38. [38] Cunningham, M.A., Wirth, J.R., Freeman, L.R., Boger, H.A., Granholm, A.C., Gilkeson, G.S., Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. J. Neuroinflammation, 11, 2014 (171-014-0171-x.).
39. [39] Xia, Y., Pawar, R.D., Nakouzi, A.S., Herlitz, L., Broder, A., Liu, K., Goilav, B., Fan, M., Wang, L., Li, Q.Z., Casadevall, A., Putterman, C., The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. J. Autoimmun. 39 (2012), 398–411.
40. [40] Thurmond, T.S., Murante, F.G., Staples, J.E., Silverstone, A.E., Korach, K.S., Gasiewicz, T.A., Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 141 (2000), 2309–2318.
41. [41] Erlandsson, M.C., Jonsson, C.A., Islander, U., Ohlsson, C., Carlsten, H., Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 108 (2003), 346–351.
42. [42] Grimaldi, C.M., Michael, D.J., Diamond, B., Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167 (2001), 1886–1890.
43. [43] Couse, J.F., Curtis, S.W., Washburn, T.F., Lindzey, J., Golding, T.S., Lubahn, D.B., Smithies, O., Korach, K.S., Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9 (1995), 1441–1454.
44. [44] Heffner, C.S., Pratt, C.H., Babiuk, R.P., Sharma, Y., Rockood, S.F., Donahue, L.R., Eppig, J.T., Murray, S.A., Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat. Commun., 3, 2012, 1218.
45. [45] Janbandhu, V.C., Moik, D., Fassler, R., Cre recombinase induces DNA damage and tetraploidy in the absence of loxP sites. Cell Cycle 13 (2014), 462–470.
46. [46] Thyagarajan, B., Guimaraes, M.J., Groth, A.C., Calos, M.P., Mammalian genomes contain active recombinase recognition sites. Gene 244 (2000), 47–54.
47. [47] Semprini, S., Troup, T.J., Kotelevtseva, N., King, K., Davis, J.R., Mullins, L.J., Chapman, K.E., Dunbar, D.R., Mullins, J.J., Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res. 35 (2007), 1402–1410.
48. [48] Potter, P.K., Cortes-Hernandez, J., Quartier, P., Botto, M., Walport, M.J., Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J. Immunol. 170 (2003), 3223–3232.
49. [49] Licht, R., Dieker, J.W., Jacobs, C.W., Tax, W.J., Berden, J.H., Decreased phagocytosis of apoptotic cells in diseased SLE mice. J. Autoimmun. 22 (2004), 139–145.
50. [50] Rickert, R.C., Rajewsky, K., Roes, J., Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376 (1995), 352–355.
51. [51] Watanabe, R., Ishiura, N., Nakashima, H., Kuwano, Y., Okochi, H., Tamaki, K., Sato, S., Tedder, T.F., Fujimoto, M., Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol. 184 (2010), 4801–4809.